VEXAS syndrome – newly described autoinflammatory disease with haematologic symptoms. Case report and review of the literature
Authors:
Z. Adam 1; J. Mayer 1; D. Frič 1; J. Kissová 1; M. Jarošová 1; M. Beličková 2; L. Kratochvílová 3; T. Freiberger 3,4; L. Červinek 1; P. Komínková 5; Z. Řehák 6; Z. Král 1
Authors‘ workplace:
Interní hematologická a onkologická klinika LF MU a FN Brno
1; Ústav hematologie a krevní transfuze, Praha
2; Genetická laboratoř, Centrum kardiovaskulární a transplantační chirurgie Brno
3; Ústav klinické imunologie a alergologie, LF MU Brno
4; Revmatologická ambulance, Nemocnice Jindřichův Hradec
5; Oddělení nukleární medicíny, Masarykův onkologický ústav Brno
6
Published in:
Transfuze Hematol. dnes,30, 2024, No. Ahead of Print, p. 1-8.
Category:
Review/Educational Papers
doi:
https://doi.org/10.48095/cctahd2024prolekare.cz7
Labels
Haematology Internal medicine Clinical oncologyArticle was published in
Transfusion and Haematology Today
2024 Issue Ahead of Print
Most read in this issue
- VEXAS syndrome – newly described autoinflammatory disease with haematologic symptoms. Case report and review of the literature
- Rare granulomatous processes
- VEXAS syndrome – a diagnosis at the interface of rheumatology and haematology
- Disorders induced by deposits of monoclonal immunoglobulin IgM and free light Chain in Waldenström’s macroglobulinaemia – case report and review of literature